net loss

InVivo’s Q2 net loss hits $10.4M as spinal cord injury trial shows early success: 5 things to know

By Laura Dyrda InVivo Therapeutics reported $10.4 million net loss in the second quarter of 2015. However, CEO Mark Perrin is focused…